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The two most common forms of COPD, chronic 
bronchitis and pulmonary emphysema, will be briefly 
reviewed. 
Etiology. The causes of COPD are not definitely 
known. However, there appears to be a statistically 
significant correlation between the incidence of 
COPD, cigarette smoking, and air pollution. This is 
especially true for chronic bronchitis. In some cases, 
genetic factors (alpha1 - antitrypsin deficiency) may 
be responsible for development of COPD. This is 
called familial type of COPD or familial emphysema. 
Chronic irritation of the tracheobronchial tree is 
common to all cases of chronic bronchitis. Cigarette 
smoking appears to be the single most important 
factor in the development of chronic bronchitis. 
Heavy cigarette smokers appear to be affected to a 
greater extent than light smokers, and the symptoms 
are worse in patients who give a history of long 
cigarette smoking. However, not all cigarette smokers 
develop chronic bronchitis. Individual susceptibility 
may play a role in some people. The symptoms of 
smoking are greater if a person lives in a heavily 
polluted area and also if there is cold and damp 
weather. 
The Incidence. It has been estimated that there 
are currently 15 million people suffering from COPD 
in the United States. The incidence of COPD is 
higher in industrial areas, especially among men 
who engage in dusty jobs, such as coal miners. 
Mortality. In the United States in 1969, 35,000 
died primarily from chronic bronchitis and pulmo-
nary emphysema. In 65,000 cases chronic bronchitis 
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and pulmonary emphysema contributed to the demise 
of the patients. Since 1950, the death rate from 
emphysema has doubled every five years. The federal 
government pays more than $200,000,000 annually 
to respiratory cripples. 
Definition. Chronic bronchitis is a clinical syn-
drome which is characterized by productive cough 
on most days during at least three months a year 
for two or more successive years. There is chronic 
productive cough without known specific causes 
such as tuberculosis or chronic suppurative lung 
disease. It is more common in males. 
There is excessive mucous production with hy-
pertrophy and hyperplasia of the mucous secreting 
glands including the Goblet cells. Bronchial mucous 
glands are normally located in the bronchi which 
contain cartilage in their wall. Hypertrophy of the 
gland size can be measured as a gland to wall ratio, 
and this is called the Reid Index. In normal people 
over the age of four years, this falls below one-third. 
In children under the age of four years, the ratio 
is a little higher. 
A high Reid Index is very suggestive of chronic 
bronchitis, but there is no close correlation between 
clinical chronic bronchitis and the degree of mucous 
gland hypertrophy and hyperplasia. There is also an 
overlap of the Reid Index between bronchitis and 
non bronchitis. 
Clinical and Functional Manifestations of 
Chronic Bronchitis. The cardinal manifestation of 
chronic bronchitis is productive cough. There is in 
general a history of 20-30 years of cigarette smoking. 
The disease in general has a slow onset. In the begin-
ning, patients attribute the cough to cigarette smok-
ing. The so-called "cigarette cough" is an early sign of 
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bronchitis. In many patients there is also an as-
sociated chronic sinusitis. The cough may disappear 
if smoking is stopped early enough. 
The activity of cilia in the bronchial tree is in-
hibited by tobacco smoke. As a result of this, move-
ment of mucous blanket is reduced significantly. 
The mucous glands and Goblet cells are stimulated 
and they produce more mucous. The result will 
be chronic cough and expectoration. 
Excessive mucous production increases the ten-
dency to infection which causes further hypersecre-
tion. There develops a vicious cycle of excessive 
mucous secretion, infection, and more hypersecretion 
results. Tobacco smoke also causes bronchoconstric-
tion which may aggravate the symptoms of bronchitis. 
Normally the lower respiratory tract is es-
sentially sterile. This is primarily due to cough re-
flexes, mucociliary, and alveolar macrophagic 
activity that eliminates bacteria or foreign particles 
that may have been inhaled during inspiration. 
In chronic bronchitis many organisms can be 
isolated from the sputum which may be responsible 
for acute exacerbations. However, viruses prob-
ably are responsible to a great extent for the acute 
episodes in chronic bronchitis. 
Following viral infections, as a result of damage 
to bronchial mucous, growth of bacteria may be en-
couraged. Diplococcus pneumoniae and Hemophilus 
influenzae appear to be important organisms; how-
ever, sometimes Staphylococcus aureus and the 
Friedlander's bacillus may be responsible for acute 
infection . Some patients trace the beginning of 
symptoms to some acute episode of infection such 
as bronchopneumonia. 
In general there is fluctuation in the mani-
festations during the course of the disease. Symp-
toms become worse after exposure to cold, damp, or 
foggy weather or to irritants. However, during the 
end-stage of the disease the patients are, more or 
less, continuously symptomatic. Death secondary to 
pneumonia, congestive heart failure, or acute re-
spiratory failure may occur 15 to 30 years after the 
beginning of symptoms. In a typical bronchitic, 
sputum is usually mucoid which becomes muco-
purulent during acute bronchopulmonary infections. 
Dyspnea may also occur during episodes of 
acute bronchoconstriction secondary to infections, 
irritants, and so forth. It may also indicate develop-
ment complicating pulmonary emphysema. Inter-
mittent wheezing may also be present. 
Dyspnea, cough, and wheezing may awaken 
the patient, and the picture may be confused 
with paroxysmal nocturnal dyspnea due to left-sided 
heart failure. But in bronchitis the symptoms are 
generally improved by expectoration of sputum. The 
body weight of thes'e patients is generally normal or 
heavy. 
Arterial gas abnormalities are quite common. 
Many patients have hypoxemia alone. CO~ retention 
takes place late in the course of the disease or 
during acute episodes of bronchopulmonary infection. 
When hypoxemia and respiratory acidosis are 
present, pulmonary hypertension develops which 
may result in cor pulmonale. 
There is a high incidence of erythrocytosis 
resulting from hypoxemia. Many patients later in 
the course of the disease have florid appearance 
and cyanosis. Because of increased incidence of 
congestive heart failure and cyanosis, the patients 
are called "Blue Bloaters." 
The amount of airway obstruction will in-
fluence the physical signs. In advanced stages, the 
thoracic cage is in the inspiratory position. There 
is kyphosis of the dorsal spine. The anteroposterior 
diameter of the chest increases. There is excessive 
use of accessory respiratory muscles. The degree 
of scalene muscle contraction may give an idea 
about the extent of airway obstruction. In general, 
the breath sounds are normal. Ronchi are present 
in most patients. 
In the early stages of chronic bronchitis and 
pulmonary emphysema, there is a significant de-
gree of involvement of the small airways. It should 
be emphasized that small airways (2 mm or less in 
diameter) are only responsible for approximately 
15 to 20% of the total airway resistance ; thus, 
marked increases in peripheral or small airways will 
not be detected by the conventional tests such as 
FEV1 (forced expiratory volume in one second) 
or MMFR (maximum mid expiratory flow rate). 
In the early stages of these conditions, frequency-
dependent dynamic compliance studies and alveolar-
arterial 0 2 tension gradient, A-a P0 ,, may detect 
pulmonary dysfunction. For clinical purposes, how-
ever, simple spirometric studies with measurements 
of FVC (forced vital capacity), FEV1 and MMFR 
are satisfactory. 
Improvements in flow rates after administration 
of bronchodilating agents indicate the presence of 
partially reversible obstruction. 
In established chronic bronchitis, there is 
over-expansion of the lungs with enlargement of 
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residual volume and FRC (functional residual ca-
pacity). VC ( vital capacity) is either normal or 
decreased. The total lung capacity may be normal 
or increased. The ratio between FEV1 and FVC, 
and the maximal mid expiratory flow rate are reduced. 
Radiologic Findings. In simple or uncomplicated 
chronic bronchitis, the chest x-ray may be normal. 
There may be over-expansion of the lungs and the 
diaphragm may be depressed. 
Some cases would show "tram lines" or parallel 
shadows and prominence of the lung markings mainly 
at the bases. Prominence of the main pulmonary 
artery may suggest pulmonary hypertension. Bron-
chograms may demonstrate tiny diverticulum-like 
shadows in the large bronchi. Irregularity of the 
caliber of segmental and subsegmental bronchi is 
frequently seen. 
Pulmonary Emphysema. Pulmonary emphysema 
is accurately defined in morphologic terms only. It 
is defined by increase beyond normal in the size 
of air spaces distal to the terminal bronchioles, 
with destruction of the walls of these air spaces. It 
is a destructive process. There is reduction in elastic 
retractive force of the lungs. 
The portion of the lung distal to the terminal 
bronchiole is called acinus, and it contains respiratory 
bronchioles, alveolar ducts, alveolar sacs, and alveoli. 
It is in this area that gas exchange takes place. For 
this reason, acinus is considered as the basic func-
tioning unit of the lungs which is analogous to the 
nephron of the kidney. 
In panacinar emphysema, there is involvement 
of the entire acinus. In centriacinar emphysema, 
only those alveoli near the center of the acinus are 
affected. The centriacinar type is more common in 
the upper two-thirds, and the panacinar is roughly 
uniform, commonly affecting the basal regions of 
the lungs. 
Many patients have both types of emphysema 
together; however, centriacinar is much more com-
mon than panacinar and is in general associated 
with chronic bronchitis and chronic respiratory irri-
tation. Dr. W. M. Thurlbeck found panacinar as 
often in women as men, while the centriacinar was 
more common in men. 
Emphysema is more common in patients with 
bronchitis than in nonbronchitics . There is also a 
higher incidence of emphysema in patients with 
extensive bronchiectasis. This is also true in other 
chronic inflammatory diseases of the lungs, espe-
cially when both lungs are diffusely affected. On the 
other hand, emphysema is rarely found in the post-
mortem studies of the lungs of patients with bronchial 
asthma. 
Clinical and Functional Manifestations. The 
main symptom of emphysema is dyspnea which 
has an insidious onset and becomes manifested on 
exertion. Dyspnea gradually increases, and in ad-
vanced stages, ordinary daily activities may induce 
severe shortness of breath. 
Cough may be absent or insignificant during 
the early course of the disease. Episodes of severe 
dyspnea and wheezing may occur, usually during 
acute bronchopulmonary infections or after exposure 
to irritants. In general, the body weight is below 
normal, and loss of weight is common in emphy-
sematous patients. 
The anteroposterior diameter of the chest is 
increased. Breath sounds are distant. The heart 
sounds are frequently inaudible. They may be heard 
easily in the epigastric area. There is a higher in-
cidence of peptic ulcer disease in patients with 
emphysema. The exact cause of this is unknown at 
the present time. 
Airway resistance is increased especially dur-
ing expiration. Static compliance of the lungs is 
greater than normal. However, frequency dependent 
compliance studies are generally abnormal. Residual 
volume, FRC, and TLC (total lung capacity) are 
frequently elevated. VC may be normal or reduced 
due to increased RV and FRC. There is obstruction 
to airflow. FEV1, MMFR, and MVV (maximal 
voluntary ventilation) are diminished. 
X-ray Findings. In mild pulmonary emphysema 
the chest x-ray may be normal. In some cases there 
is x-ray evidence of over-expansion of the lungs 
which is a nonspecific finding that is seen in cases 
of diffuse bronchial obstruction such as bronchial 
asthma and chronic bronchitis. If, in addition to over-
expansion, there is marked reduction or absence of 
peripheral vascular markings associated with en-
gorged hilar pulmonary vessels and blebs bullae, 
presence of underlying emphysema is almost certain. 
The heart shadow is usually long and narrow. 
Arterial gas studies reveal only mild abnormalities 
at least during early stages of the disease. Patients 
attempt to maintain a relatively normal P0 , and Pc0 ,. 
Because of this, these patients are called " Pink 
Puffers." The incidence of cor pulmonale is less 
frequent in Pink Puffers as compared with Blue 
Bloaters. 
There are two primary factors responsible for 
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TABLE 1. 
MAIN MANIFFSTATIONS OF PURE CHRONIC BRONCHITIS 
OR PULMONARY EMPHYSEMA 
Cough 
Dyspnea 
Body Weight 
Arterial Gas 
Abnormalities 
Cor Pulmonale 
Erythrocytosis 
Breath Sounds 
± : Insignificant 
+: Increase 
(Blue Bloater) 
Chronic 
Bronchitis 
++++ 
± 
normal or 
heavy 
++++ 
++++ 
++++ 
normal 
+ + + +: Significant increase 
(Pink Puffer) 
Pulmonary 
Emphysema 
± 
++++ 
thin 
+ 
+ (Terminally) 
+ 
diminished 
the development of pulmonary hypertension in pa-
tients with COPD: 1) Functional or reversible fac-
tors due to hypoxemia and hypercapnia, 2) Irre-
versible factors due to loss or occlusion of pulmonary 
capillaries. 
Functional factors are mainly responsible, and 
they play a major role in the production of pulmonary 
hypertension. Since there are in general more dis~ 
turbed arterial gas tensions in bronchitis, incidence of 
pulmonary hypertension and cor pulmonale are 
higher in bronchitics. 
In over 90% of the cases of COPD, patients 
have combined chronic bronchitis and pulmonary 
emphysema. Some of these patients have predom-
inantly chronic bronchitis and some predominantly 
pulmonary emphysema. However, a very small per-
centage of . these patients would only have either 
chronic bronchitis or pure pulmonary emphysema. 
TABLE 2. 
CAUSES OF ACUTE RESPIRATORY FAILURE IN COPD 
1. Bronchopulmonary infections. 
2. Heavy sedation and anesthesia. 
3. Improper use of oxygen. 
4. Pulmonary edema and congestion. 
5. Thoracotomy, abdominal surgery. 
6. Atelectasis or pneumothorax. 
7. Dehydration. 
8. Pulmonary embolism. 
9. Severe episode of air pollution. 
TABLE 3. 
THE FINDINGS THAT MAY INDICATE POOR PROGNOSIS 
IN COPD 
1. Recent significant weight loss. 
2. Persistent tachycardia at rest. 
3. Presence of cor pulmonale. 
4. FEV1 less than 750 ml. 
5. Persistent severe hypoxemia and hypercapnia. 
6. Marked reduction in pulmonary diffusion capacity. 
If manifestations due to pure chronic bronchitis 
or emphysema are appreciated, one may have some 
opinion as to symptoms and signs primarily related 
to either chronic bronchitis or pulmonary emphy-
sema (Table 1 ) . It has been shown that chronic 
bronchitis does not necessarily always lead to pul-
monary emphysema nor does pulmonary emphy-
sema always lead to chronic bronchitis. 
Table 2 shows causes of acute respiratory failure 
in patients who have chronic respiratory failure 
with COPD. Finally, Table 3 shows factors that 
may indicate poor prognosis in patients with COPD. 
Comment. There are currently 15 million peo-
ple affected with COPD in the United States. It 
appears that once the disease is well established or 
advanced, the ultimate course cannot be altered 
significantly. Emphasis should be given upon pro-
phylactic measures. Discouragement of cigarette 
smoking is probably the most important means to 
reduce the incidence of COPD. 
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